Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Return on Equity: 2011-2012

Historic Return on Equity for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Dec 2012 value amounting to -3.48%.

  • Sonoma Pharmaceuticals' Return on Equity rose 52889.00% to -3.48% in Q4 2012 from the same period last year, while for Dec 2012 it was -3.48%, marking a year-over-year increase of 52889.00%. This contributed to the annual value of -17.75% for FY2012, which is N/A change from last year.
  • According to the latest figures from Q4 2012, Sonoma Pharmaceuticals' Return on Equity is -3.48%, which was down 104.44% from 78.43% recorded in Q3 2012.
  • Sonoma Pharmaceuticals' Return on Equity's 5-year high stood at 78.43% during Q3 2012, with a 5-year trough of -532.37% in Q4 2011.
  • Its 2-year average for Return on Equity is -67.83%, with a median of -3.48% in 2012.
  • Data for Sonoma Pharmaceuticals' Return on Equity shows a peak YoY soared of 52,889bps (in 2012) over the last 5 years.
  • Over the past 2 years, Sonoma Pharmaceuticals' Return on Equity (Quarterly) stood at -532.37% in 2011, then soared by 52,889bps to -3.48% in 2012.
  • Its last three reported values are -3.48% in Q4 2012, 78.43% for Q3 2012, and 22.81% during Q2 2012.